195 related articles for article (PubMed ID: 21548715)
1. AMP-activated protein kinase modulators: a patent review (2006 - 2010).
Yun H; Ha J
Expert Opin Ther Pat; 2011 Jul; 21(7):983-1005. PubMed ID: 21548715
[TBL] [Abstract][Full Text] [Related]
2. Direct AMP-activated protein kinase activators: a review of evidence from the patent literature.
Giordanetto F; Karis D
Expert Opin Ther Pat; 2012 Dec; 22(12):1467-77. PubMed ID: 23136886
[TBL] [Abstract][Full Text] [Related]
3. Screening methods for AMP-activated protein kinase modulators: a patent review.
Kim J; Shin J; Ha J
Expert Opin Ther Pat; 2015 Mar; 25(3):261-77. PubMed ID: 25535089
[TBL] [Abstract][Full Text] [Related]
4. AMP-activated protein kinase: a target for old drugs against diabetes and cancer.
Russo GL; Russo M; Ungaro P
Biochem Pharmacol; 2013 Aug; 86(3):339-50. PubMed ID: 23747347
[TBL] [Abstract][Full Text] [Related]
5. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer.
Fogarty S; Hardie DG
Biochim Biophys Acta; 2010 Mar; 1804(3):581-91. PubMed ID: 19778642
[TBL] [Abstract][Full Text] [Related]
6. Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.
Popovics P; Frigo DE; Schally AV; Rick FG
Expert Opin Ther Targets; 2015 May; 19(5):617-32. PubMed ID: 25600663
[TBL] [Abstract][Full Text] [Related]
7. AMP-activated protein kinase activators in diabetic ulcers: from animal studies to Phase II drugs under investigation.
Lin JT; Chen HM; Chiu CH; Liang YJ
Expert Opin Investig Drugs; 2014 Sep; 23(9):1253-65. PubMed ID: 24857754
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Targeting of AMP-Activated Protein Kinase and Opportunities for Computer-Aided Drug Design.
Miglianico M; Nicolaes GA; Neumann D
J Med Chem; 2016 Apr; 59(7):2879-93. PubMed ID: 26510622
[TBL] [Abstract][Full Text] [Related]
9. AMPK activators--potential therapeutics for metabolic and other diseases.
Zhou G; Sebhat IK; Zhang BB
Acta Physiol (Oxf); 2009 May; 196(1):175-90. PubMed ID: 19245659
[TBL] [Abstract][Full Text] [Related]
10. Targeting of AMP-activated protein kinase: prospects for computer-aided drug design.
Kim J; Yang G; Ha J
Expert Opin Drug Discov; 2017 Jan; 12(1):47-59. PubMed ID: 27797589
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present).
Lamers C; Schubert-Zsilavecz M; Merk D
Expert Opin Ther Pat; 2012 Jul; 22(7):803-41. PubMed ID: 22697317
[TBL] [Abstract][Full Text] [Related]
12. AMPK as a mediator of hormonal signalling.
Lim CT; Kola B; Korbonits M
J Mol Endocrinol; 2010 Feb; 44(2):87-97. PubMed ID: 19625456
[TBL] [Abstract][Full Text] [Related]
13. Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).
Marzaro G; Guiotto A; Chilin A
Expert Opin Ther Pat; 2012 Mar; 22(3):223-52. PubMed ID: 22404097
[TBL] [Abstract][Full Text] [Related]
14. Recent patents in the discovery of small molecule inhibitors of JAK3.
Wilson LJ
Expert Opin Ther Pat; 2010 May; 20(5):609-23. PubMed ID: 20402545
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase CK2 inhibitors: a patent review.
Cozza G; Pinna LA; Moro S
Expert Opin Ther Pat; 2012 Sep; 22(9):1081-97. PubMed ID: 22908959
[TBL] [Abstract][Full Text] [Related]
16. Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies.
Martelli AM; Chiarini F; Evangelisti C; Ognibene A; Bressanin D; Billi AM; Manzoli L; Cappellini A; McCubrey JA
Expert Opin Ther Targets; 2012 Jul; 16(7):729-42. PubMed ID: 22686561
[TBL] [Abstract][Full Text] [Related]
17. p21-Activated kinase inhibitors: a patent review.
Crawford JJ; Hoeflich KP; Rudolph J
Expert Opin Ther Pat; 2012 Mar; 22(3):293-310. PubMed ID: 22404134
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation.
Lin JN; Lin VC; Rau KM; Shieh PC; Kuo DH; Shieh JC; Chen WJ; Tsai SC; Way TD
J Agric Food Chem; 2010 Feb; 58(3):1584-92. PubMed ID: 19928762
[TBL] [Abstract][Full Text] [Related]
19. Promise and challenges for direct small molecule AMPK activators.
Olivier S; Foretz M; Viollet B
Biochem Pharmacol; 2018 Jul; 153():147-158. PubMed ID: 29408352
[TBL] [Abstract][Full Text] [Related]
20. Potential upstream regulators and downstream targets of AMP-activated kinase signaling during oocyte maturation in a marine worm.
Stricker SA
Reproduction; 2011 Jul; 142(1):29-39. PubMed ID: 21474604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
